This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Solaero Med Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Tamer Y El Mays: Innovator in Respiratory Disease Treatment
Introduction
Tamer Y El Mays is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of respiratory medicine, particularly in the treatment of diseases affecting the airways. His innovative approach has the potential to improve the quality of life for many individuals suffering from respiratory conditions.
Latest Patents
Tamer Y El Mays holds a patent for a method of treating respiratory diseases. This patent addresses conditions characterized by acute intermittent or chronic obstruction of the airways, such as asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. The treatment involves delivering a perfluorocarbon and a gas mixture comprising carbon dioxide to the lungs of the affected mammal. This method not only provides acute relief from airway obstruction but also allows for the subsequent delivery of additional active agents from conventional treatments.
Career Highlights
Throughout his career, Tamer has worked with various companies, including Solaero Med Inc. and Uti Limited Partnership. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.
Collaborations
Tamer has collaborated with notable professionals in his field, including Francis H Y Green and Samuel Schurch. These collaborations have further enhanced his research and development efforts in respiratory disease treatment.
Conclusion
Tamer Y El Mays is a pioneering inventor whose work in respiratory disease treatment showcases his commitment to improving healthcare outcomes. His innovative methods and collaborations highlight the importance of research in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile